Evidence map›Paper›PMID 25645379›Full record

ArticleJournal of neurovirology2015

A herpes simplex virus type 1 mutant disrupted for microRNA H2 with increased neurovirulence and rate of reactivation.

Xianzhi Jiang, Don Brown, Nelson Osorio, Chinhui Hsiang, Lily Li, Lucas Chan, Lbachir BenMohamed, Steven L Wechsler

Open access · greenAbstract read
In one paragraph

Article in Journal of neurovirology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. MicroRNAs in Ocular Infection.Microorganisms · 2019
    Review
  16. Article
  17. [Mechanisms of herpes simplex virus latency and reactivation].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2019
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xianzhi JiangVirology Research, Gavin Herbert Eye Institute and Department of Ophthalmology, School of Medicine, University of California, Irvine, 843 Health Sciences Road, Hewitt Hall (Building 843), Room 2012, Irvine, CA, 92697, USA.
Don Brown
Nelson Osorio
Chinhui Hsiang
Lily Li
Lucas Chan
Lbachir BenMohamed
Steven L Wechsler
University of California, Irvine · US

Funding

University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Corneal HSV-1: LAT's Anti-Apoptosis Activity and LatencyR01EY013191 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI WECHSLER, STEVEN L · 2001 to 2013
$6.9M
Therapeutic Ocular HSV Vaccine in HLA Transgenic RabbitsR01EY019896 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI BENMOHAMED, LBACHIR · 2010 to 2025
$5.1M
Ocular Mucsoal Immunity Induced by HSV-1 LipopeptidesR01EY014900 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI BENMOHAMED, LBACHIR · 2003 to 2014
$3.1M
Blockade of T-cell Co-Inhibitory Pathways & Immunotherapy to Prevent Ocular HerpeR01EY024618 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI BENMOHAMED, LBACHIR · 2014 to 2016
$1.2M
HSV-1 LAT miRNAs: Neurovirulence, reactivation, mechanismR56AI098985 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI WECHSLER, STEVEN L · 2013 to 2013
$421k
Corneal HSV-1: Newly discovered LAT miRNAs and latencyR56AI093133 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI WECHSLER, STEVEN L · 2011 to 2011
$383k
NCATS NIH HHS UL1 TR001414NEI NIH HHS R01 EY013191NEI NIH HHS R01EY013191NEI NIH HHS R01 EY014900NEI NIH HHS R01 EY019896NEI NIH HHS R01EY019896NEI NIH HHS R01 EY024618NEI NIH HHS R01EY14900NIAID NIH HHS 1R56AI093133NIAID NIH HHS 1R56AI098985NIAID NIH HHS R56 AI093133NIAID NIH HHS R56 AI098985
6 · The paper itself

Abstract

The herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) encodes several microRNAs. One of these, miR-H2, overlaps and is antisense to the ICP0 gene and appears to decrease expression of the ICP0 protein. To determine if miR-H2 plays a role in the HSV-1 latency-reactivation cycle, we constructed a mutant, McK-ΔH2, in which this microRNA has been disrupted without altering the predicted amino acid sequence of ICP0. McK-ΔH2 produced increased amounts of ICP0. Although replication of McK-ΔH2 was similar to that of its wild-type (wt) McKrae parental virus in RS cells and mouse eyes, McK-ΔH2 was more neurovirulent in Swiss-Webster mice than McKrae based on the percent of mice that died from herpes encephalitis following ocular infection. In addition, using a mouse trigeminal ganglia (TG) explant model of induced reactivation, we show here for the first time that miR-H2 appears to play a role in modulating HSV-1 reactivation. Although the percent of TG from which virus reactivated by day 10 after explant was similar for McK-ΔH2, wt McKrae, and the marker-rescued virus McK-ΔH2Res, at earlier times, significantly more reactivation was seen with McK-ΔH2. Our results suggest that in the context of the virus, miR-H2 downregulates ICP0 and this moderates both HSV-1 neurovirulence and reactivation.

Indexed as

AnimalsDisease Models, AnimalFemaleGene Expression Regulation, ViralHerpes SimplexHerpesvirus 1, HumanImmediate-Early ProteinsImmunoblottingMiceMice, Inbred C57BLMice, TransgenicMicroRNAsReverse Transcriptase Polymerase Chain ReactionRNA, ViralUbiquitin-Protein LigasesVirulenceImmediate-Early Proteinslatency associated transcript, herpes simplex virus-1MicroRNAsRNA, ViralUbiquitin-Protein LigasesVmw110 protein, Human herpesvirus 1

Identifiers

PMID25645379
PMCPMC4375036
OpenAlexW1976235448

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.